期刊文献+

重组融合蛋白rTMP—GH促进放射损伤小鼠血小板生成的实验研究

Effect of rTMP-GH recombinant fusion protein on thrombocytopoiesis in irradiation injured mice
原文传递
导出
摘要 目的研究TPO模拟肽(TMP)与人生长激素(GH)的重组融合蛋白rTMP-GH对放射损伤小鼠血小板生成的促进作用。方法^60Coγ射线全身一次性均匀照射5Gy,照后皮下注射200μg/kg的rTMP—GH或rhGH,每日1次,连续用药7d,对照组给予同等体积生理盐水。尾静脉取血检测血小板数量变化;照后16d取小鼠股骨,组织切片观察骨髓病理变化。结果照后10d起,rTMP-GH处理组各时相的外周血血小板数明显高于rhGH处理组和生理盐水对照组,尤其是血小板的最低值显著升高(P〈0.01),照后22d已升至正常水平的80%,对照组仅为30%。骨髓病理观察显示,rTMP—GH处理组骨髓造血重建明显,并见大量不同时期巨核细胞;rTMP-GH处理组骨髓组织切片每个视野下的巨核细胞平均数(3.07±0.32)明显高于rhGH处理组(2.20±0.22,P〈0.05)和生理盐水对照组(0.87±0.19,P〈0.01)。结论rTMP-GH能快速、有效地促进放射损伤小鼠骨髓巨核细胞增年和向小析年矗. Objective To investigate the in vivo effects of rTMP-GH recombinant fusion protein on thrombocytopoiesis in mice with thrombopenia inflicted by irradiation. Methods BALB/C mice weighting around 20 g were irradiated with 5 Gy of ^60Co γ-ray irradiation to generate thrombopenia. The irradiation injured mice were injected with rTMP-GH or rhGH subcutaneously at the dose of 200μg·kg^-1·d^-1 for 7 days. From the 6 th day, the platelets in blood samples from vena caudalis were counted routinely, and the pathological changes of bone marrow were determined by morphological observation. Results From the 10 th day, the levels of blood platelet in rTMP-GH treated mice were much higher than those of rhGH treatment group and normal saline (NS) control group, especially at the nadir (P 〈 0.01). On the 22 nd day, the platelet count has recovered up to 80% of normal level in rTMP-GH treatment group, while it has just recovered up to 30% in NS control group. Morphological observation showed that there was obvious reconstruction of bone marrow in mice treated with rTMP- GH, compared with NS group. The number of megarkaryoblasts and megakaryocytes in bone marrow of rTMP-GH treated mice (3.07 ± 0.32) was much higher than those of rhGH treatment group (2.20 ± 0.22, P 〈 0.05) and NS control group (0.87 ± 0.19, P 〈 0.01 ). Conclusions rTMP-GH has potent effects on the recovery of blood platelet by promoting megarkaryocytopoiesis in irradiation injuried mice.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2009年第6期583-585,共3页 Chinese Journal of Radiological Medicine and Protection
基金 国家863计划(2007AA02Z152) 国家教委高校全国优博论文专项资金(200362) 新药创制科技专项(2008ZXJ09003-011)
关键词 TPO模拟肽 生长激素 放射损伤 血小板生成 Thrombopoietin mimetic peptide Growth hormone Irradiation injury Thrombocytopoiesis
  • 相关文献

参考文献10

  • 1Deutsch VR, Tomer A. Megakaryocyte development and platelet production. Br J Haematol, 2006, 134(5) : 453-466.
  • 2邵波,艾国平,王军平,刘晓宏,肖燕,冉新泽,开丽,粟永萍.新型升血小板因子静脉注射在小鼠体内的靶向性实验研究[J].重庆医学,2006,35(18):1679-1680. 被引量:4
  • 3许杨,王军平,赵景宏,粟永萍,陈芳,申明强,陈默,王崧,开丽.重组融合蛋白rTMP-GH对体外培养巨核细胞增殖的影响[J].第三军医大学学报,2008,30(1):1-4. 被引量:6
  • 4Wang B, Nichol JL, Sullivan JT. Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Clin Pharmacol Ther,2004, 76(6):628-638.
  • 5Serres M, Ellis B, Dillberger JE, et al. Immunogenicity of thrombopoietin mimetic peptide GW395058 in BALB/c mice and New Zealand white rabbits: evaluation of the potential for thrombopoletin neutralizing antibody production in man. Stem Cells, 1999, 17(4) : 203-209.
  • 6Kumagal Y, Fujita T, Ozaki M, et al. Pharmaeodynamies and pharmacokinetics of AMG 531, a thrombopoiesis-stimulating peptibody, in healthy Japanese subjects: a randomized, placebocontrolled study. J Clin Pharmaeol, 2007, 47(12) : 1489-1497.
  • 7Stasi R, Evangelista ML, Amadori S. Novel thrombopoictie agents: a review of their use in idiopathic thrombocytopenic purpura. Drugs, 2008,68(7) :901-912.
  • 8Tian ZG, Woody MA, Sun R, et al. Recombinant human growth hormone promotes hematopoietic reeonstitution after syngeneic bone marrow transplantation in mice. Stem Cells, 1998,16(3):193-199.
  • 9Bakker B, Oostdijk W, Geskus RB, et al. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood. Clin Endocrlnol (Oxf), 2007,67(4):589-597.
  • 10Sirohi B, Powles R, Morgan G, et al. Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study. Bone Marrow Transplant, 2007,39(2) :115-120.

二级参考文献17

  • 1刘林,张曦,罗成基,粟永萍,陈幸华.腺病毒载体介导的TPO基因疗法对放射损伤小鼠造血功能重建的影响[J].重庆医学,2005,34(9):1286-1288. 被引量:1
  • 2邵波,艾国平,王军平,刘晓宏,肖燕,冉新泽,开丽,粟永萍.新型升血小板因子静脉注射在小鼠体内的靶向性实验研究[J].重庆医学,2006,35(18):1679-1680. 被引量:4
  • 3Cwirla SE,Balasubramanian P,Duffin DJ,et al.Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine[J].Science,1997,276(5319):1696
  • 4Illum L,Davis SS.Targeting of colloidal particles to the bone marrow[J].Life Sci,1987,40(16):1553
  • 5Moghimi SM,Illum L,Davis SS.Physiopathological and physicochemical considerations in targeting of colloid samnd drug carriers to the bone marrow[J].Cri Rev Thera Drug Carrier Sys,1990,7(3):187
  • 6Deutsch V R,Tomer A.Megakaryocyte development and platelet production[J].Br J Haematol,2006,134(5):453 -466.
  • 7Nakamura T,Miyakawa Y,Miyamura A,et al.A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis[J].Blood,2006,107 (11):4300-4307.
  • 8Cwirla S E,Balasubramanian P,Duffin D J,et al.Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine[J].Science,1997,276(5319):1696-1699.
  • 9Li J,Yang C,Xia Y,et al.Thrombocytopenia caused by the development of antibodies to thrombopoietin[J].Blood,2001,98 (12):3241-3248.
  • 10Bussel J B,Kuter D J,George J N,et al.AMG 531,a thrombopoiesis-stimulating protein,for chronic ITP[J].N Engl J Med,2006,335(16):1672-1681.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部